President CVPath/Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States
Dr. Finn is an interventional cardiologist and internationally recognized expert in the field of vascular biology and vascular device research. He currently serves as Medical Director and Chief of Research of CVPath and is head of the Institute’s basic and translational research laboratory. He is also an Associate Professor of Medicine at the University of Maryland, where he serves as a cardiologist and interventional cardiologist.
He has published over 150 peer-reviewed research articles, editorials, and reviews and is the recipient of multiple research awards pertaining to his work in vascular biology.
Disclosure information not submitted.
Vulnerable Plaque 2025 | Where Do We Stand from the Pathologic Perspective?
Sunday, March 9, 2025
10:23 AM – 10:31 AM ET
Debate | No - Its Not Time Yet for PCI of Vulnerable Plaque
Sunday, March 9, 2025
10:55 AM – 11:03 AM ET
Science and Myths Behind Device-Based Technology
Sunday, March 9, 2025
8:00 AM – 8:08 AM ET
Sunday, March 9, 2025
7:30 PM – 7:35 PM ET
Sunday, March 9, 2025
7:43 PM – 7:48 PM ET
Sunday, March 9, 2025
7:56 PM – 8:01 PM ET
Sunday, March 9, 2025
8:11 PM – 8:16 PM ET
Panel Discussion: The Future of DCB in the US
Sunday, March 9, 2025
8:24 PM – 8:35 PM ET
Comparing DCB’s | Drug Design Matters – Preclinical
Monday, March 10, 2025
8:00 AM – 8:08 AM ET
Panel Discussion | DCB for Coronary Applications
Monday, March 10, 2025
9:04 AM – 9:20 AM ET
Calcium and PAD | What Therapies are Best?
Monday, March 10, 2025
8:40 AM – 8:48 AM ET
Panel Discussion | PAD: Diagnosis, Treatment, and Definitive Therapy Options
Monday, March 10, 2025
9:20 AM – 9:40 AM ET